icad inc

$3.22
(as of Apr 17, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for icad inc

Stock Price
$3.22
Ticker Symbol
ICAD
Exchange
NASDAQ

Industry Information for icad inc

Sector
Healthcare
Industry
Medical Devices

Company Description for icad inc

Country
USA
Full Time Employees
66

iCAD, Inc. engages in the AI-powered cancer detection solutions in the United States. The ProFound Breast Health Suite offers solutions for"breast"cancer detection, breast density assessment, one- or two-year breast cancer risk evaluation, and cardiovascular risk assessment related to elevated levels of breast arterial calcifications; as well as it also enables medical providers and professionals to accurately and reliably identify where cancer may be hiding. Its Detection solutions include advanced artificial intelligence and image analysis workflow solutions to identifying pathologies and pinpointing prevalent cancers earlier, a comprehensive range of upgradeable computer-aided detection systems and workflow solutions for digital breast tomosynthesis, full-field digital mammography, magnetic resonance imaging and computed tomography. In addition, the company suite offers solutions for cancer detection, density assessment, and personalized risk evaluation, all based on a 2D or 3D mammogram's collection of images. Additionally, its density assessment standardizes and simplifies breast density reporting, algorithmically examining a woman's breast anatomy from the mammogram image. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.

Fundamentals for icad inc

Market Capitalization
$88,117,552
EBITDA
$-5,460,000
Dividends per Share
P/E Ratio
Forward P/E Ratio
0
Earnings per Share
$-0.21
Earnings per Share Estimate Next Year
Profit Margin
-28.64%
Shares Outstanding
27,365,700
Percent Owned by Insiders
5.62%
Percent Owned by Institutions
20.39%
52-Week High
52-Week Low

Technical Indicators for icad inc

50-Day Moving Average
200-Day Moving Average
RSI
74.48
0.27

Analyst Ratings for icad inc

Strong Buy
3
Buy
1
Hold
0
Sell
0
Strong Sell
0

News About icad inc

Apr 16, 2025, 7:35 PM EST
NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: See more.
Apr 15, 2025, 4:01 PM EST
The acquisition will unite complementary leading AI-powered cancer detection and workflow solutions focused on improving the accuracy and early detection of breast cancerThe transaction is expected to add to RadNet’s wholly owned subsidiary, DeepHealth, an installed base of over 1,500 healthcare provider locations across over 50 countriesWith iCAD’s seasoned commercial and engineering team anticipated to join DeepHealth, the combination is expected to accelerate RadNet’s growth and leadership in cancer screening and artificial intelligenceFollowing the completion of the acquisition, iCAD will be integrated into RadNet’s DeepHealth portfolio of solutionsRadNet will host a conference call and webcast at 10:30 a.m. See more.
Apr 15, 2025, 4:01 PM EST
RadNet, Inc. See more.
Apr 8, 2025, 10:19 AM EST
NASHUA, N.H., April 08, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. See more.